Addus HomeCare (NASDAQ:ADUS) Stock Rating Upgraded by StockNews.com

Addus HomeCare (NASDAQ:ADUS) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday.

A number of other equities research analysts also recently commented on the company. Bank of America lifted their price objective on Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a research report on Tuesday, May 7th. Stephens increased their price objective on shares of Addus HomeCare from $120.00 to $128.00 and gave the stock an “overweight” rating in a report on Friday, May 31st. Macquarie assumed coverage on shares of Addus HomeCare in a report on Friday. They issued an “outperform” rating and a $136.00 target price for the company. Oppenheimer increased their price target on shares of Addus HomeCare from $118.00 to $130.00 and gave the stock an “outperform” rating in a research note on Friday, June 7th. Finally, Barclays lowered Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 target price on the stock. in a research report on Tuesday, April 23rd. One analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $116.25.

Addus HomeCare Stock Up 1.7 %

Shares of NASDAQ ADUS opened at $116.11 on Friday. The firm’s 50-day moving average is $109.70 and its two-hundred day moving average is $99.97. The company has a market capitalization of $1.90 billion, a PE ratio of 28.81, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02. Addus HomeCare has a 12-month low of $78.35 and a 12-month high of $120.53. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.35 and a quick ratio of 1.35.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, May 6th. The company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.24. The firm had revenue of $280.70 million during the quarter, compared to analysts’ expectations of $279.49 million. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The firm’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.84 EPS. Equities analysts anticipate that Addus HomeCare will post 4.36 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 217 shares of the stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $116.13, for a total value of $25,200.21. Following the completion of the sale, the executive vice president now owns 10,217 shares in the company, valued at $1,186,500.21. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 4.60% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Addus HomeCare

Large investors have recently added to or reduced their stakes in the company. HighTower Advisors LLC purchased a new position in Addus HomeCare in the 3rd quarter valued at about $455,000. Deutsche Bank AG increased its holdings in Addus HomeCare by 15.3% during the 3rd quarter. Deutsche Bank AG now owns 9,353 shares of the company’s stock worth $797,000 after purchasing an additional 1,243 shares during the last quarter. Rhumbline Advisers raised its position in shares of Addus HomeCare by 0.8% in the 3rd quarter. Rhumbline Advisers now owns 48,218 shares of the company’s stock valued at $4,108,000 after purchasing an additional 376 shares in the last quarter. Envestnet Asset Management Inc. boosted its stake in shares of Addus HomeCare by 72.0% during the 3rd quarter. Envestnet Asset Management Inc. now owns 48,328 shares of the company’s stock valued at $4,117,000 after buying an additional 20,236 shares during the last quarter. Finally, Mariner LLC boosted its stake in shares of Addus HomeCare by 5.5% during the 3rd quarter. Mariner LLC now owns 6,621 shares of the company’s stock valued at $564,000 after buying an additional 346 shares during the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.